Dr. Jennifer Rose Jorgensen, MD

Dr. Jorgensen practices at Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut.

Dr. Jorgensen's NPI, 1023368370, was assigned on September 13, 2012. Dr. Jorgensen graduated from Boston University School of Medicine in 2012. Dr. Jorgensen holds Connecticut license 062656.

Dr. Jorgensen's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD, at 263 Farmington Ave, Farmington, CT 06030.

Dr. Jorgensen's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut. Dr. Jorgensen is also affiliated with UConn John Dempsey Hospital. The medical group on file is Trinity Health Of New England Medical Group. Dmand AI also links Dr. Jorgensen to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jorgensen practices, 2 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Jorgensen's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Jorgensen is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Jorgensen is licensed in Connecticut.

CMS data shows 135 Medicare services from Dr. Jorgensen across 4 procedure codes in 2024, for 48 Medicare patients. Medicare paid $8,735 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 48 Medicare patients who saw Dr. Jorgensen in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 38% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jorgensen's median patient age at 72, with 99% women.

In 2024, Dr. Jorgensen wrote 190 Medicare Part D claims for 54 patients. 82% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $10,407 in total drug cost. In 2022, CMS named 13 claims across 1 drug.

Dr. Jorgensen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jorgensen as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Jorgensen, published from 2018 to 2025. The most frequent topics are Ovarian Neoplasms. Dr. Jorgensen's most frequent co-authors are Shayan Dioun, MD, Christopher Michael Morosky, MD and Nicole S. Nevadunsky.

CMS Open Payments shows 9 general payments to Dr. Jorgensen from 3 drug and device companies from 2017 to 2024. Travel and lodging make up the largest share, 71% of the total. Medical Device Business Services, Inc. paid the most, $867.

Dr. Jorgensen graduated from Boston University School of Medicine in 2012.